Your browser doesn't support javascript.
loading
[Parardoxical reaction following tuberculosis treatment in non HIV-infected patients]. / Les réactions paradoxales au cours du traitement de la tuberculose (hors infection par le VIH).
Kassegne, L; Bourgarit, A; Fraisse, P.
Affiliation
  • Kassegne L; Service de pneumologie, Nouvel hôpital civil, hôpitaux universitaires de Strasbourg, 1, place de l'hôpital, 67000 Strasbourg cedex, France. Electronic address: loic.kassegne@chru-strasbourg.fr.
  • Bourgarit A; Université Paris 13, Bobigny, France; Service de médecine interne, hôpital Jean-Verdier, HUPSSD AP-HP, Bondy, France; Inserm U1135, centre d'immunologie et des maladies infectieuses, 75013 Paris, France.
  • Fraisse P; Service de pneumologie, Nouvel hôpital civil, hôpitaux universitaires de Strasbourg, 1, place de l'hôpital, 67000 Strasbourg cedex, France; Groupe pour l'enseignement et la recherche en pneumo-infectiologie de la SPLF, 66, boulevard Saint-Michel, 75006 Paris, France.
Rev Mal Respir ; 37(5): 399-411, 2020 May.
Article in Fr | MEDLINE | ID: mdl-32386802
ABSTRACT
A paradoxical reaction is the worsening of prior existing, or the appearance of, new tuberculous lesions, following the initiation of treatment with anti-tuberculous drugs, after the exclusion of poor compliance, malabsorption, drug interaction or multiresistant mycobacteria. Well known and well managed in the context of HIV coinfection, it is not well known outside this context. An increasing number of publications have described this syndrome. This review aims to describe the pathogenic, epidemiological, clinical, prognostic and therapeutic elements of non-HIV-associated paradoxical reactions. It involves a reversal of the Mycobacterium tuberculosis-induced immunodepression along with a heightened detrimental pro-inflammatory profile caused by efficient drug treatment. Extra-thoracic locations, especially lymph nodes and neurological, malnutrition and initial lymphopenia are the principal risk factors. The median delay is 40±20 days after the onset of treatment. Corticosteroids are the mainstay of the management. Anti-TNF-α drugs show good results in corticosteroid refractory cases. The prognosis is good overall except in neurological forms. The place of preventive methods remains to be established.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Disease Progression / Antitubercular Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Fr Journal: Rev Mal Respir Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Disease Progression / Antitubercular Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Fr Journal: Rev Mal Respir Year: 2020 Document type: Article